Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Q2 FY2019 Earnings Presentation
13 slides from Narayana Hrudayalaya's earnings presentation, Oct 31, 2018
Slide 1: Narayana Health submission letter to exchanges
Av NtNarayana Health™ Date of Submission: 31" October 2018 To To The Secretary The Secretary Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Bandra Kurfa Complex Phiroze Jeejeebhoy Towers, Mumbai-400 050 Dala
Slide 2: Investor Presentation October 2018
Investor Presentation October 2018
Slide 3: Important Disclosure
Important Disclosure No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its da
Slide 4: NH at a Glance
NH at a Glance As on 30th Sep 2018 NH’s footprint in India 50 Healthcare Facilities Operational beds 21 Owned / Operated Hospitals(1) 5,243 Beds Kakriyal, Jammu Northern Region 2 Managed Hospitals(2) 498 Beds 3 hospitals Operational beds: 586 7 Heart Centres 371 Beds 19 Primary Healthcare Facilities
Slide 5: Key Highlights
Key Highlights ▪ Narayana Superspeciality Hospital, Howrah performed the first case of extracorporeal radiotherapy in Eastern India ▪ NH establishes strategic foray into Bangladesh by entering into partnership for operating cardiac sciences department in a state-of-the art soon to be commissioned 35
Slide 6: Revenue Mix – India Business (Q2 FY19)
Revenue Mix – India Business (Q2 FY19) Operating Revenues Business Mix INR mn 12,000 10,803 94% 5% 6,229 1% 5,592 (1) Owned / Operated Hospitals Heart Centres (2) Other Anciliary Businesses Q2 FY18 Q2 FY19 H1 FY18 H1 FY19 Speciality-Profile(7,8) Payee-Profile(3,8) Maturity-Wise(5) Cluster-Wise(5,6)
Slide 7: Operational Review – India Business
Operational Review – India Business Operational Beds(1) Occupied Bed Count(2) 2,870 2,783 5,889 6,228 30th Sep 2017 30th Sep 2018 Q2 FY18 Q2 FY19 ARPOB(2) ALOS(2) INR mn Days 8.8 7.7 4.2 3.9 Q2 FY18 Q2 FY19 Q2 FY18 Q2 FY19 (1) Includes Cayman Islands Hospital and Managed Hospitals (2) Excludes Manag
Slide 8: Operational Review – HCCI
Operational Review – HCCI ARPOB Occupied Bed Count US$ mn 31 24 1.9 1.7 Q2 FY18 Q2 FY19 Q2 FY18 Q2 FY19 Operating Revenues Profitability US$ mn US$ mn 12.7 EBITDA EBITDA Margin (%) 11.6 15.9% 14.3% 1.8 1.8 0.0 Q2 FY18 Q2 FY19 Q2 FY18 Q2 FY19 7
Slide 9: Regional Profile – India Business (Q2 FY19)
Regional Profile – India Business (Q2 FY19) Region Hospitals(1) Hospital % of Hospital Operational Parameters(1) Operating Revenues(1) Operational Beds(1,3) % of Total YoY Growth ARPOB (INR mn) Occupancy Karnataka 44% 40% 6 9.8 57% Region 3% Eastern 8 33% 32% 7.8 68% Region 11% For Q2 FY19 Western 1
Slide 10: Maturity Profile – India Business (Q2 FY19)
Maturity Profile – India Business (Q2 FY19) Maturity(1) Hospitals (Exc. Hospital % of Hospital Key Performance Indicators(2) Managed Hospitals)(2) Operating Revenues(2) Operational Beds(2,5) % of Total YoY Growth ARPOB (INR mn) Occupancy EBITDAR Margin(3) Over 5 years 11 72% 69% 8.8 61% 23.5% 7% As
Slide 11: Profitability Snapshot – India Business
Profitability Snapshot – India Business EBITDA and EBITDA Margin Cost Structure INR mn Movement across New Hospitals % of Operating Revenues Q2 FY18 Q2 FY19 Losses Revenues Losses Revenues 89.6% Rental / Revenue Share 90.6% SRCC 78 36 SRCC 66 115 Dharamshila -9 186 Dharamshila 20 253 Gurugram 0 0 Gu
Slide 12: Consolidated Financial Performance
Consolidated Financial Performance Figures in INR mn, unless stated otherwise Profit and Loss Statement(1) Key Balance Sheet Items(1) Particulars (INR mn) Q2 FY19 H1 FY19 Particulars 30th September 2018 Total Operating Revenue 7,113 13,636 Purchase of Medical Consumables, Drugs Shareholder Equity 10
Slide 13: Shareholding Pattern
Shareholding Pattern Shareholding as on 30th September 2018(1) Total Number of Shares 204,360,804 ESOP Trust Others 0.9% 3.3% PE Investors 13.1%(3) CDC - 7.9% Asia Growth Capital - 5.2% FIIs / DIIs and Retail 18.9% Promoter Group FIIs - 10.3% 63.9%(2) DIIs - 4.1% Retail - 4.5% (1) Percentages might
Narayana Hrudayalaya — Q2 FY2019 Earnings Presentation on 6ix